Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer
Clinical trial NCT01061515 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01061515
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-10
- Primary completion
- 2026-09-27
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.